Access cutting-edge heterozygous familial hypercholesterolemia treatment through this clinical trial at a research site in Dothan. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Dothan location
Preparing your pre-screening questions…
Access heterozygous familial hypercholesterolemia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heterozygous familial hypercholesterolemia treatment provided free
Check if you qualify for this heterozygous familial hypercholesterolemia clinical trial in Dothan, AL
No-Cost Study Care
Local to Dothan
Convenient for AL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
VT-10201 is an Open-label, Phase 1b, Single-ascending Dose Study That Will Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia (HeFH) or Premature Coronary Artery Disease (CAD) Who Require Additional Lowering of LDL-C. VERVE-102 Uses Base-editing Technology Designed to Disrupt the Expression of the PCSK9 Gene in the Liver and Lower Circulating PCSK9 and LDL-C. This Study is Designed to Determine the Safety and Pharmacodynamic Profile of VERVE-102 in This Patient Population.
Sponsor: Verve Therapeutics, Inc.
Yes, this clinical trial (NCT06164730) has an active research site in Dothan, AL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for heterozygous familial hypercholesterolemia treatment options in Dothan, AL, this clinical trial (NCT06164730) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dothan research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heterozygous familial hypercholesterolemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all heterozygous familial hypercholesterolemia clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Dothan — not just this study.
Browse Heart Attack Trials in Dothan →